Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes

Australian Family Physician.

PubMed · 1984 · 2.5K citations

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Richard Piekarz, Robin Frye, Maria L. Turner et al. · Journal of Clinical Oncology · 2009 · 737 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

Guillermo Garcia‐Manero, Hui Yang, Carlos E. Bueso‐Ramos et al. · Blood · 2007 · 461 citations

Medicine, Hematology, Oncology +16

Anti‐rheumatic activities of histone deacetylase (HDAC) inhibitors <i>in vivo</i> in collagen‐induced arthritis in rodents

Ching Yuan Hu, Y‐Y Liew, H‐P Huang et al. · British Journal of Pharmacology · 2007 · 274 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

Collin M. Blakely, Evangelos Pazarentzos, Victor Olivas et al. · Cell Reports · 2015 · 203 citations · Full text

Medicine, Cancer Biology, Oncology +15